C-Cell Carcinoma (Medullary Thyroid Carcinoma) Associated with Multiple Endocrine Neoplasms in a Ferret (Mustela putorius)

J. G. Fox, C. A. DANGLER, S. B. SNYDER, M. J. RICHARD, AND J. P. THILSTED

Abstract. A firm, infiltrative mass was found in the thyroid region of an adult castrated male ferret (Mustela putorius) presenting with vague signs of weight loss, minor inappetence, and decreased activity. Efforts to surgically excise the tissue were unsuccessful, and the animal was euthanatized. Gross and histopathologic evaluation revealed multiple endocrine neoplasms, including C-cell carcinoma, adrenocortical adenoma, pheo- chromocytoma, and endocrine tumor of the pancreas. This is the first descriptive account of a C-cell carcinoma, also known as medullary thyroid carcinoma, in a ferret, although other endocrine neoplasms in this species have been reported with some frequency. These findings mimic features observed in human multiple endocrine neoplasia syndromes.

Key words: C-cell carcinoma; ferrets.

The ferret (Mustela putorius) has become increasingly popular as a companion animal in the United States; there was a reported estimate of 10-12 million pet ferrets in US households as of the mid-1980s. Thus, more detailed anal- yses of their disease states have been undertaken during the past decade.5 Endocrine tumors are the most common neo- plasms reported in this species, and the preponderance of these have been adrenocortical tumors and pancreatic islet cell tumors. Thyroid adenomas and a thyroid adenocarci- noma have been listed in a multi-institutional database on ferret tumors, but descriptive information was not given.5,8 The purpose of this report is to describe the first case of C- cell carcinoma concurrent with other endocrine neoplasms in a ferret.

A castrated male ferret was purchased from a laboratory animal supplier (Marshall Farms, North Rose, NY) at 10 weeks of age to serve as an educational animal in a zoolog- ical collection. It was housed singly in a room with mixed species of small mammals and birds and had been vaccinated against canine distemper (Fevac-D, United Vaccine) and ra- bies (Imrab 1, Rhone Merieux). The diet was dry cat food daily and a small amount of moist diet twice weekly. At approximately 31 months of age, the ferret exhibited poor appetite, moderately thin body condition, and a thin haircoat

bilaterally on the chest and abdominal walls and on the tail. The diet was changed to a more palatable cat food (Max Cat Adult, Nutro Products), and a skin and haircoat conditioner (Nutraderm, SmithKline Beecham) was given. The condition resolved within several weeks.

The next abnormal sign was seen at 45 months of age, when the ferret was found in a semiconscious condition. This condition was transient and resolved within a few hours without treatment. Over the next 2 months, the ferret exhib- ited subtle, abnormal signs of reduced activity, diminished appetite, and some loss of luster to the haircoat. When the animal was presented for diagnostic work-up, it was afebrile and weighed 962 g, a decrease from 1,350 g 1 year earlier. Physical examination revealed a prominent soft tissue mass in the right thyroid region. The zookeeper recalled hearing short bouts of choking or coughing over the past 2 months, but because of their brevity, the symptoms were not brought to the attention of the veterinary staff.

Radiographs showed a left ventral deviation of the tra- chea. The fine needle aspiration was not diagnostic. Serum biochemistry data showed all values, including calcium, within normal limits, with the exception of an elevated lac- tate dehydrogenase, which was 1,837 IU/liter (range, 241- 752 IU/liter), a marginally elevated globulin of 3.1 g/dl

(range, 2-2.9 g/dl), and a fasting glucose value of 65 mg/dl (range, 107-138 mg/dl). The total T4 was 1.0 µg/dl (range, 1.01-8.29 µg/dl), but the sample was of insufficient quantity for a complete thyroid profile.5 The tentative diagnosis of thyroid neoplasia or possible cystic thyroid was made. Sur- gical exploration under general anesthesia was performed 2 weeks after the initial diagnostic evaluation. Euthanasia was performed following an unsuccessful effort to excise the thy- roid mass in toto.

A dense, poorly circumscribed, dark red vascular mass of 3 × 2 × 2 cm was removed from the thyroid region. It was tightly adherent to all contiguous tissues, making dissection and complete removal of the abnormal tissue impossible. The left thyroid gland appeared to be relatively normal. There was prominent and rounded enlargement (5-6 mm diameter) of both adrenal glands. The pancreas was grossly normal. Other organs and tissues had no significant gross lesions, although the brain and pituitary gland were not ex- amined. Tissues were collected from the excised thyroid mass, from the opposite thyroid, and from the adrenal gland, heart, lung, liver, spleen, pancreas, kidney, and abdominal lymph node. Samples were placed in 10% buffered formalin for fixation and histologic preparation using standard meth- ods for light microscopy.

The thyroid mass had histologic features characteristic of an endocrine neoplasm and more consistent with a C-cell origin than a thyroid follicular epithelium origin. The mass was comprised of irregular cords, lobules, and smaller nests of neoplastic epithelium interdigitated with a dense, arbor- izing fibroblastic response. At one edge, the neoplastic tissue invaded an adjacent lymph node. In the well-differentiated regions, the neoplastic cells were organized in lobules or cords, generally two to four cells broad, and were arranged in palisades of columnar cells along the thin fibrovascular septa or the abutting fibrous stroma (Fig. 1). Cells within the interior of the lobules and cords were polyhedral or spindle shaped. The cells had scant to moderate amounts of pale pink vesicular cytoplasm with indistinct borders. The nuclei were round to fusiform with indented nuclear margins and pale vesicular chromatin with small nucleoli. Mitotic figures were rare (6/10 high-power fields).

In several broad areas of the thyroid mass, the fibroblastic response was the dominant component and enclosed small nests of anaplastic cells (Fig. 2). In other areas, trabeculae of anaplastic cells also contained a lymphocytic infiltrate. Infrequent small nests of follicles lined by simple cuboidal epithelium and enclosed by an eosinophilic matrix or an in- tense lymphocytic infiltrate were present in one section of the mass.

Consistent with their neuroendocrine derivation, numer- ous fine argyrophilic granules were present in the cytoplasm of most neoplastic cells in the thyroid tumor when stained with a modified Grimelius procedure (Fig. 3).12 Calcitonin immunostain using human anti-calcitonin reagents was un- successful (C. Capen, unpublished data). Failure was likely due to either lack of cross-species reactivity of human re- agents to ferret antigens or destruction of antigenic sites by prolonged formalin preservation.

The tumor was evaluated for the presence of amyloid by staining with Congo red and examination under polarized

light. Multifocal birefringence with an apple-green hue was associated primarily with the fibrous stroma, which divided the mass and encircled neoplastic cells. This pattern of bi- refringence overlapped but was distinct from the intense white birefringence of the dense collagen stroma. This pat- tern of collagen-associated birefringence was also present in sections stained with hematoxylin and eosin.

The nonneoplastic left thyroid tissue contained an intense, diffuse interstitial infiltrate comprised chiefly of lympho- cytes. The glandular parenchyma was comprised of follicles containing colloid and sloughed epithelial cells and of ag- gregates of C cells.

Among the tissues presented for histologic evaluation, several extrathyroid sites of endocrine neoplasia were ob- served. The pancreas contained a discrete, nonencapsulated tumor comprised of mildly anaplastic islet cells, which pro- jected short distances into the adjacent exocrine tissue. The cells were organized in closely packed cords separated by limited fibrovascular stroma and had eosinophilic cytoplasm and ovoid basophilic nuclei. Two small nonencapsulated metastatic foci of endocrine lineage were also observed in the hepatic parenchyma and were comprised of closely packed cords of polyhedral cells with pale vesicular cyto- plasm and round basophilic nuclei. The hepatic foci histo- logically resembled the pancreatic islet tumor and well-dif- ferentiated portions of the thyroid carcinoma. The origin of the metastases was not wholly established; however, the ten- dency of pancreatic islet tumors to infiltrate the liver sug- gests this tissue as the primary source.

One adrenal gland was available for histologic evaluation. This gland contained multiple neoplastic foci, which ob- scured the normal adrenal architecture (Fig. 4). Two large, expansile, sharply demarcated foci were comprised of close- ly packed nests of small polyhedral cells, which had lightly basophilic cytoplasm and round nuclei of moderate size with indented margins, marginated and finely granular chromatin, and prominent nucleoli. These cells did not stain with a mod- ified Grimelius procedure.12 These foci resembled adreno- cortical adenomas with small cell morphology, as previously described in ferrets.5 An adjacent, histologically distinct fo- cus was partially displaced by the adrenocortical adenoma and was comprised of polyhedral to elongate cells arranged in sheets and smaller closely packed lobules separated by branching fibrous septa. The cells had abundant granular or finely vacuolated, densely eosinophilic cytoplasm and small, round basophilic nuclei with smudged homogeneous chro- matin staining. This focus contained clusters of densely ar- gyrophilic cells (Fig. 5) separated by cells with variable ex- pression of fine argyrophilic cytoplasmic granules (Fig. 6), suggestive of adrenomedullary origin (i.e., pheochromocytoma).

No pathologic changes were observed in other tissues ex- amined histologically, with the exception of chronic bron- chitis and bronchiolitis in the lung characterized by mono- nuclear cell infiltration around airways, peribronchiolar smooth muscle cell hyperplasia, and epithelial hyperplasia.

Endocrine neoplasms are the most commonly observed tumors in ferrets. In a recent review of a multi-institution database, tumors of endocrine origin were identified in 39.7% of ferrets affected with neoplasms.8 Although endo-

Fig. 1. Thyroid tumor; ferret. In well-differentiated regions, the lobules and cords of neoplastic neuroendocrine cells are separated by thin septa of branching fibrovascular stroma. HE. Bar = 100 um. Fig. 2. Thyroid tumor; ferret. The fibroblastic response is disproportionately high in many regions of the neoplasm. Nests of anaplastic cells are enclosed by the fibroblastic response. HE. Bar = 100 um. Fig. 3. Thyroid tumor; ferret. The cords of neoplastic cells (*) contain fine argyrophilic, cytoplasmic granules. Small aggregates of argyrophilic cells (arrows) are also isolated in the enclosing stroma. Grimelius. Bar = 30 um. Fig. 4. Adrenal tumors; ferret. A dark staining sheet of small neoplastic cells (right) expands and displaces another pale staining multilobulated, neoplastic focus (pale region on left). HE. Bar = 350 um. Fig. 5. Adrenal tumor; ferret. Densely argyrophilic cells, resembling adrenal medullary cells are present in small nests among similar cells with fine granule content. Grimelius. Bar = 40 um. Fig. 6. Adrenal tumor; ferret. One neoplastic focus contains sheets of polyhedral cells with variable expression of fine argyrophilic granules, in contrast to the densely stained cells in Fig. 5. Cells with notable perinuclear condensation of the argyrophilic granules (arrows) are present among other cells with more sparse granule density. Grimelius. Bar = 25 um.

2

3

A

4

I

5

6

crine tissues, such as the adrenal cortex and the pancreatic islets, are the most frequent origins of ferret neoplasms, this C-cell carcinoma, reported in ferrets for the first time, oc- curred in tandem with other extrathyroid endocrine neo- plasms. The histologic features of the thyroid neoplasm were distinctive and consistent with a C-cell origin. The C-cell lineage was further confirmed and differentiated from thy- roid follicular cells by the intense argyrophilia of tumor cells revealed with Grimelius stain. The histologic pattern of this C-cell carcinoma most closely resembled the clear cell pat- tern described in a survey of C-cell carcinomas in dogs.14 A pattern of Congo red staining and birefringence centered on dense collagen stroma was also observed within the tumor, similar to that described in a majority of the canine tumors.14 The presence of amyloid in neoplastic tissue is also a hall- mark feature of medullary thyroid carcinoma in humans.3 Care was taken to discriminate the amyloid-associated pat- tern of birefringence from the strong, nonspecific birefrin- gence of the dense collagen stroma. The diagnosis of C-cell carcinoma is consistent with a lack of elevated serum thy- roxine in this ferret. The nonneoplastic thyroid with the lym- phocytic infiltrate suggests an immune system-mediated in- sult that might further reduce thyroid hormone levels. Although some dogs with C-cell carcinoma may have hy- pocalcemia, many dogs with this type of tumor, like the ferret in this case, have normal serum calcium levels.2

C-cell carcinomas have been frequently observed in aged bulls and rats, in contrast to other domestic and laboratory animal species. Although early reports suggested that C-cell tumors are rare in dogs, in a recent survey of thyroid tumors in dogs, 12 of 38 (36%) were C-cell carcinomas; this is a much higher frequency of this tumor type than previously reported in dogs.2 In bulls, pheochromocytomas are also of- ten observed in tandem with C-cell carcinomas.1 In a recent review of Fischer 344 rats used in long-term carcinogenicity studies, pheochromocytomas and C-cell carcinomas were in- dependently observed in 31.9% and 14.8%, respectively, of male rats used in feeding trials.6 In a recently published ret- rospective study, six of 72 horses with endocrine tumors had concurrent C-cell tumors and pheochromocytomas.4 Al- though adrenocortical neoplasms are exceptionally common in ferrets, pheochromocytomas are rarely reported.8 Conse- quently, the presented case is further distinguished by the concurrence of a pheochromocytoma and a C-cell carcinoma.

Although the range of clinical signs in ferrets with mul- tiple endocrine neoplasms can be quite heterogeneous, signs due to one or more prominent lesions can predominate over others. The principal clinical features of this case, i.e., grad- ual weight loss, partial anorexia, reduced activity, and col- lapse, are probably related to the islet cell tumor and not to the C-cell carcinoma. The fasting glucose level of 65 mg/dl is highly suggestive of hypoglycemia due to excessive in- sulin secretion by the tumor.7,9 The bilateral hair loss noted prior to the onset of signs of hypoglycemia is consistent with elevated adrenal steroids observed in ferrets with adrenal tumors.8 Recurring and progressive hair loss are prominent features of hyperadrenocorticism in the ferret. Estrogenic steroids (e.g., 17 ß-estradiol) synthesized in the adrenal tu-

mor have been implicated in adrenal tumor-associated alo- pecia in ferrets.

The coincidence of medullary thyroid neoplasms and oth- er endocrine tumors is also observed in several heritable syn- dromes of human disease. There are three main categories of multiple endocrine neoplasia (MEN) syndromes in hu- mans, of which two, MEN-IIA and MEN-IIB, have a high incidence of C-cell neoplasia accompanied by pheochro- mocytomas.3 The MEN-IIA and -IIB syndromes are associ- ated with mutations of the RET proto-oncogene.10,13 Expres- sion of a mutated RET gene in transgenic mice has recently been reported to precipitate C-cell hyperplasia and C-cell carcinomas morphologically similar to those seen in humans with MEN-II syndromes.11 Similarly, an earlier report linked expression of the mos proto-oncogene in several lines of transgenic mice to a high frequency of pheochromocytomas and C-cell neoplasms, suggesting an association with the pathogenesis of MEN-II syndromes.15

The third category of MEN syndrome in humans, MEN- I, is associated with a unique gene locus (MEN-I) and typified by tumors of the pituitary, pancreatic islets, and parathyroid gland; adrenocortical and C-cell tumors may also be observed in this syndrome. The concurrence of adrenocortical, pancreatic islet, and C-cell tumors in this ferret, in part, parallel features of the human MEN-I syndrome.

The observed similarities between the manifested neo- plasms in this ferret and MEN syndromes in humans are tantalizing but incomplete. The presence or absence of other MEN-associated neuroendocrine lesions, such as pituitary tumor, parathyroid cell adenoma, or mucosal neuromas, which would support further MEN subclassification, could not be confirmed in this ferret. Likewise, the presence of a RET or mos proto-oncogene mutation or mutation in the MEN-I gene in this ferret has not been established. It is hoped that this report will stimulate further studies to elu- cidate whether the ferret has a heritable form of MEN com- parable to that documented in humans.

Acknowledgements

We acknowledge the assistance of Dr. C. Capen in the histologic evaluation of the C-cell carcinoma. This work was supported in part by NIH grant RR07036.

Reference

1 Capen CC, Black HE: Animal model of human disease. Medullary thyroid carcinoma, multiple endocrine neo- plasia, Sipple’s syndrome. Animal model: ultimobran- chial thyroid neoplasm in the bull. Am J Pathol 74:377- 380, 1974

2 Carver JR, Kapatkin A, Patnaik AK: A comparison of medullary thyroid carcinoma and thyroid adenocarcino- ma in dogs: a retrospective study of 38 cases. Vet Surg 24:315-319, 1995

3 Cotran RS, Kumar V, Collins T, Robbins SL: Robbins Pathologic Basis of Disease, 6th ed. WB Saunders, Phil- adelphia, PA, 1998

4 De Cock HEV, MacLachlan NJ: Simultaneous occur- rence of multiple neoplasms and hyperplasias in the ad-

renal and thyroid gland of the horse resembling multiple endocrine neoplasia syndrome: case report and retro- spective identification of additional cases. Vet Pathol 36: 633-636, 1999

5 Fox JG: Biology and Diseases of the Ferret, 2nd ed. Wil- liams and Wilkins, Baltimore, MD, 1998

6 Haseman J, Hailey JR, Morris RW: Spontaneous neo- plasm incidence in Fischer 344 rats and B6C3F, mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 26:428-441, 1998

7 Jenkins JR, Brown SA: A Practitioner’s Guide to Rabbits and Ferrets. American Animal Hospital Association, Lakewood, 1993

8 Li X, Fox JG, Padrid PA: Neoplastic diseases in ferrets (Mustela putorius furo): a review of veterinary medical data base (1968-1997). J Am Vet Med Assoc 22:1402- 1406, 1998

9 Marini RP, Ryden EB, Rosenblad WD, Murphy JC, Fox JG: Functional islet cell tumor in six ferrets. J Am Med Assoc 202:430-433, 1993

10 Marsh DJ, McDowall D, Hyland VJ, Andrew SD, Schnitzler M, Gaskin EL, Nevell DF, Diamond T, Del- bridge L, Clifton-Bligh P, Robinson BG: The identifi- cation of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. Clin Endocrinol 44:213-220, 1996

11 Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J, Billaud M: De- velopment of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci USA 94:3330-3335, 1997

12 Pascual JS: A new method for easy demonstration of argyrophil cells. Stain Techol 51:231-235, 1976

13 Pasini B, Ceccherini I, Romeo G: RET mutations in hu- man disease. Trends Genet 12:138-144, 1996

14 Patnaik AK, Lieberman PH: Gross, histologic, cyto- chemical, and immunocytochemical study of medullary thyroid carcinoma in sixteen dogs. Vet Pathol 28:223- 233, 1991

15 Schulz N, Propst F, Rosenberg MP, Linnoila RI, Paules RS, Kovatch R, Ogiso Y, Vande Woude G: Pheochro- mocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res 52:450-455, 1992

Request reprints from Dr. J. G. Fox, Division of Compara- tive Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 16, Room 825C, Cam- bridge, MA 02139 (USA). E-mail: jgfox@mit.edu.